Brain wave test may predict ketamine success for severe depression
NCT ID NCT06480201
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study looks at whether specific brain wave patterns (gamma oscillations) can help predict how well ketamine therapy works for people with treatment-resistant depression. Researchers will measure brain activity using EEG before and during ketamine treatment and track depression symptoms over four weeks. The goal is to find a simple brain-based marker that could guide personalized treatment decisions for those who haven't benefited from other antidepressants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Texas A&M (Houston Methodist Hospital Location)
RECRUITINGHouston, Texas, 77030, United States
-
Wells Medicine
RECRUITINGHouston, Texas, 77024, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?